幹細胞の市場規模、シェア、動向分析レポート：製品別、用途別、技術別、療法別、最終用途別、地域別、セグメント別予測、2025年～2030年

幹細胞市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の幹細胞市場規模は2030年までに288億9,000万米ドルに達し、2025年から2030年までのCAGRは11.41％を記録すると予測されています。

幹細胞は、他の様々な細胞に分化し、最終的に臓器や組織を形成することができる細胞です。幹細胞の真の可能性を評価するために長年にわたって多くの研究が行われ、遺伝病治療、神経疾患、腫瘍学、臓器再生などの分野で様々な応用が進んでいます。この市場を牽引しているのは、バンク数の増加、これらの製品の治療可能性を高めることへの注目の高まり、再生医療開発のための広範な研究などです。

再生療法への注目の高まりが市場拡大の原動力となっています。iPS細胞は、カスタマイズされた細胞療法の創出のためにますます普及しており、再生医療における新たな可能性を切り開いています。例えば、2020年9月、デュークNUS大学とモナシュ大学の研究者が、妊娠中の胎盤の問題の治療に役立つ最初の幹細胞を発見しました。研究者らは、胎盤細胞の生成に使用できる人工絨毛幹細胞を作り出す新しい方法を考案しました。この研究は、体外ヒト胎盤モデルの開発に役立ち、将来の治療への道を開くものです。

さらに、COVID-19はマーケット成長を促進する触媒として作用しています。米国、中国、イランなどいくつかの国では、COVID-19感染症の治療に細胞療法を用いた臨床試験の実施を開始しています。さらに、COVID-19患者の治療に細胞療法を用いることで優れた結果が得られており、これが市場拡大に拍車をかけています。2020年1月、中国・北京の研究グループは、幹細胞治療がCOVID-19に対して有益かどうかを確かめるため、患者を対象に試験を行った。この研究では、COVID-19患者に臨床グレードのMSCを静脈内投与することで、治療の初回試験中に患者の機能的結果が改善し、回復が促進されることが判明しました。

がんの有病率の増加は、予測期間中の成長に寄与する主な要因の一つです。がん治療における併用療法や化学療法の失敗が、医師の嗜好をそうした治療から自家幹細胞療法や同種幹細胞療法へとシフトさせ、成長を後押ししています。さらに、主要な市場関係者や政府機関は、がん研究に継続的に投資しています。例えば、2021年11月、カリフォルニア再生医療研究所は、急性リンパ芽球性白血病（ALL）、慢性リンパ性白血病（CLL）、マントル細胞リンパ腫（MCL）の患者を対象とした治療に400万米ドルを投資しました。

細胞ベースの治療の使用と採用のための新技術のイントロダクションは、予測期間中の成長を促進すると予想されます。成体幹細胞と臍帯血の処理と保存の自動化は、市場成長にプラスの影響を与えると予想される主要技術です。例えば、様々な科学者が、幅広い疾患において幹細胞を用いた安全で成功する治療の承認を目指しています。2021年には、Biotech Cellinoのような企業が、自動化された幹細胞製造の開発のために人工知能技術を融合させる取り組みに7,500万米ドルを投資しました。

一方、治療費の高さが市場成長の妨げになると予想されています。例えば、幹細胞研究会社であるバイオインフォーマントの報告によると、幹細胞治療の費用は患者一人当たり5,000米ドルから8,000米ドルの間であり、処置の複雑さによっては2万5,000米ドル以上かかるケースもあるといいます。さらに、幹細胞の研究活動に対する規制が、従来から胚性幹細胞の成長を妨げてきたため、その利点にもかかわらず、市場全体のシェアはわずかなものにとどまっています。

幹細胞市場レポートハイライト

• 成体幹細胞は、胚性幹細胞のような胚の破壊を伴わないため、2024年には市場の70.76%という最大の売上シェアを占めました。
• 再生医療は、政府による再生医療開発のための資金提供の増加により、2024年の市場を独占しました。
• 細胞取得セグメントは、2024年の市場で33.43%と最も高い収益シェアを獲得しました。胚性幹細胞の発見は、いくつかの疾患に対する新規治療開発の道を開きました。
• 同種療法セグメントは、2024年に59.33％の最大収益シェアを獲得しました。
• 製薬・バイオテクノロジー企業セグメントは、2024年に54.19％の最大収益シェアを獲得しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 市場 促進要因分析
  • 市場の抑制要因と課題の分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 製品ビジネス分析

• 幹細胞市場：製品変動分析
• 成体幹細胞（ASC）
  • 成体幹細胞（ASC）市場、2018年-2030年
  • 造血
  • 間葉系
  • ニューラル
  • 上皮/皮膚
  • その他
• ヒト胚性幹細胞（HESC）
  • ヒト胚性幹細胞（HESC）市場、2018年-2030年
• 人工多能性幹細胞（iPSC）
  • 人工多能性幹細胞（iPSC）市場、2018年-2030年
• 極小胚性幹細胞
  • 極小胚性幹細胞市場、2018年-2030年

第5章 用途ビジネス分析

• 幹細胞市場：用途変動分析
• 再生医療
  • 再生医療市場、2018年-2030年
  • 神経学
  • 整形外科
  • 腫瘍学
  • 血液学
  • 心血管疾患および心筋梗塞
  • 負傷
  • 糖尿病
  • 肝疾患
  • 失禁
  • その他
• 医薬品の発見と開発
  • 医薬品の発見と開発市場、2018年-2030年

第6章 技術ビジネス分析

• 幹細胞市場：技術変動分析
• 細胞獲得
  • セル取得市場、2018年-2030年
  • 骨髄採取
  • 臍帯血
  • アフェレーシス
• 細胞生産
  • 細胞生産市場、2018年-2030年
  • 治療目的のクローン
  • 体外受精
  • 細胞培養
  • 分離
• 凍結保存
  • 凍結保存市場、2018年-2030年
• 拡大・継代培養
  • 拡大・継代培養市場、2018年-2030年

第7章 療法ビジネス分析

• 幹細胞市場：治療変動分析
• 自家移植
  • 自家移植市場、2018年-2030年
• 同種異系
  • 同種異系市場、2018年-2030年

第8章 用途ビジネス分析

• 幹細胞市場：用途変動分析
• 感染症
  • 感染症市場、2018年-2030年
• 免疫学
  • 免疫学市場、2018年-2030年
• 腫瘍学
  • 腫瘍学市場、2018年-2030年
• 幹細胞
  • 幹細胞市場、2018年-2030年
• 神経生物学
  • 神経生物学市場、2018年-2030年
• その他
  • その他の用途市場、2018年-2030年

第9章 最終用途ビジネス分析

• 幹細胞市場：最終用途変動分析
• 製薬・バイオテクノロジー企業
  • 製薬・バイオテクノロジー企業市場、2018年-2030年
• 病院と細胞バンク
  • 病院と細胞バンク市場、2018年-2030年
• 学術研究機関
  • 学術研究機関市場、2018年-2030年

第10章 地域ビジネス分析

• 地域別幹細胞市場シェア、2025年と2030年
• 北米
  • 北米の幹細胞市場、2018年-2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の幹細胞市場、2018年-2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋地域の幹細胞市場、2018年-2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの幹細胞市場、2018年-2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ幹細胞市場、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc.
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • CellGenix GmbH
  • PromoCell GmbH
  • Takara Holdings, Inc.
  • Lonza
  • Cellular Engineering Technologies
  • ATCC
  • AcceGen
  • Cell Applications, Inc.
  • Bio-Techne

List of Tables

• TABLE 1 List of Secondary Sources
• TABLE 2 List of Abbreviations
• TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 7 Global Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
• TABLE 8 Global Stem Cells Market, by Region, 2018 - 2030 (USD Million)
• TABLE 9 North America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
• TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 14 North America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 19 U.S. Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 20 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 21 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 22 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 23 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 24 Mexico Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 25 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 26 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 27 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 28 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 29 Canada Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 30 Europe Stem Cells Market, by Country, 2018 - 2030 (USD Million)
• TABLE 31 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 32 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 33 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 34 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 35 Europe Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 36 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 37 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 38 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 39 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 40 Germany Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 41 UK Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 42 UK Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 43 UK Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 44 UK Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 45 UK Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
• TABLE 46 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 47 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 48 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 49 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 50 France Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 51 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 52 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 53 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 54 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 55 Italy Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 56 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 57 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 58 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 59 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 60 Spain Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 61 Denmark Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 62 Denmark Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 63 Denmark Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 64 Denmark Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 65 Denmark Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 66 Sweden Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 67 Sweden Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 68 Sweden Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 69 Sweden Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 70 Sweden Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 71 Norway Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 72 Norway Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 73 Norway Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 74 Norway Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 75 Norway Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
• TABLE 76 Asia Pacific Stem Cells Market, by Country, 2018 - 2030 (USD Million)
• TABLE 77 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 78 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 79 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 80 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 81 Asia Pacific Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 82 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 83 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 84 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 85 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 86 China Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 87 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 88 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 89 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 90 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 91 Japan Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 92 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 93 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 94 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 95 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 96 India Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 97 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 98 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 99 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 100 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 101 South Korea Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 102 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 103 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 104 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 105 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 106 Australia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 107 Thailand Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 108 Thailand Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 109 Thailand Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 110 Thailand Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 111 Thailand Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 112 Latin America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
• TABLE 113 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 114 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 115 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 116 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 117 Latin America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 118 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 119 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 120 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 121 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 122 Brazil Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 123 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 124 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 125 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 126 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 127 Argentina Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 128 Middle East & Africa Stem Cells Market, by Country, 2018 - 2030 (USD Million)
• TABLE 129 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 130 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 131 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 132 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 133 Middle East & Africa Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 134 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 135 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 136 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 137 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 138 South Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
• TABLE 139 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 140 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 141 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 142 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 143 Saudi Arabia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 144 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 145 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 146 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 147 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 148 UAE Stem Cells Market, by End use, 2018 - 2030 (USD Million)
• TABLE 149 Kuwait Stem Cells Market, by Product 2018 - 2030 (USD Million)
• TABLE 150 Kuwait Stem Cells Market, by Application 2018 - 2030 (USD Million)
• TABLE 151 Kuwait Stem Cells Market, by Technology 2018 - 2030 (USD Million)
• TABLE 152 Kuwait Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
• TABLE 153 Kuwait Stem Cells Market, by End use, 2018 - 2030 (USD Million)

List of Figures

• FIG. 1 Market research process
• FIG. 2 Information Procurement
• FIG. 3 Primary Research Pattern
• FIG. 4 Market Research Approaches
• FIG. 5 Value Chain-Based Sizing & Forecasting
• FIG. 6 Market Formulation & Validation
• FIG. 7 Stem Cells Market Segmentation
• FIG. 8 Market Snapshot, 2024
• FIG. 9 Market Trends & Outlook
• FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
• FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• FIG. 12 PESTEL Analysis
• FIG. 13 Porter's Five Forces Analysis
• FIG. 14 Global Stem Cells Market: Product Movement Analysis
• FIG. 15 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
• FIG. 16 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
• FIG. 17 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
• FIG. 18 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
• FIG. 19 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
• FIG. 20 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
• FIG. 21 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
• FIG. 22 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
• FIG. 23 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
• FIG. 24 Global Stem Cells Market: Application Movement Analysis
• FIG. 25 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
• FIG. 26 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
• FIG. 27 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
• FIG. 28 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
• FIG. 29 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
• FIG. 30 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
• FIG. 31 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
• FIG. 32 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
• FIG. 33 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
• FIG. 34 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
• FIG. 35 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
• FIG. 36 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
• FIG. 37 Global Stem Cells Market: Technology Movement Analysis
• FIG. 38 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
• FIG. 39 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
• FIG. 40 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
• FIG. 41 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
• FIG. 42 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
• FIG. 43 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
• FIG. 44 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
• FIG. 45 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
• FIG. 46 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
• FIG. 47 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
• FIG. 48 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
• FIG. 49 Global Stem Cells Market: Therapy Movement Analysis
• FIG. 50 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
• FIG. 51 Global Stem Cells Market, for Allogeneic, 2018 - 2030 (USD Million)
• FIG. 52 Global Stem Cells Market, End-User Movement Analysis
• FIG. 53 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
• FIG. 54 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
• FIG. 55 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
• FIG. 56 Regional Outlook, 2024 & 2030
• FIG. 57 Global Stem Cells Market: Region Movement Analysis
• FIG. 58 North America Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 59 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 60 Canada Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 61 Europe Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 62 Germany Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 63 UK Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 64 France Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 65 Italy Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 66 Spain Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 67 Denmark Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 68 Norway Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 69 Sweden Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 76 Thailand Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 77 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 78 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 79 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 80 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 81 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 82 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 83 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 84 UAE Stem Cells Market, 2018 - 2030 (USD Million)
• FIG. 85 Kuwait Stem Cells Market, 2018 - 2030 (USD Million)

Stem Cells Market Growth & Trends:

The global stem cells market size is expected to reach USD 28.89 billion by 2030, registering a CAGR of 11.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery.

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective.

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages.

Stem Cells Market Report Highlights:

• Adult stem cells held the largest revenue share of 70.76% of the market in 2024 as these cells do not involve the destruction of embryos, which is the case in embryonic stem cells
• Regenerative medicine dominated the market in 2024 owing to increasing funding by the government for the development of regenerative medicines
• The cell acquisition segment captured the highest revenue share of 33.43% of the market in 2024. The discovery of embryonic stem cells has paved the way for the development of novel treatments for several diseases
• The allogenic therapy segment captured the largest revenue share of 59.33% in 2024 with regard to revenue generation
• The pharmaceutical and biotechnology companies segment captured the largest revenue share of 54.19% in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product Segment
  • 1.1.2. Application Segment
  • 1.1.3. Technology Segment
  • 1.1.4. Therapy Segment
  • 1.1.5. End-use Segment
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List Of Secondary Sources
• 1.8. List Of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Ongoing Developments In Regenerative Medicine
    • 3.2.1.2. Rising Funds For Accelerating Stem Cell Research
    • 3.2.1.3. Growing Demand For Stem Cell Banking
    • 3.2.1.4. Increasing Prevalence Of Genetic Disorders and Cancer
  • 3.2.2. Market Restraint And Challenges Analysis
    • 3.2.2.1. Ethical Concern Related To Stem Cell Research
    • 3.2.2.2. Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Stem Cells Market: Product Movement Analysis
• 4.2. Adult Stem Cells (ASCs)
  • 4.2.1. Adult Stem Cells (ASCs) Market, 2018 - 2030 (USD Billion)
  • 4.2.2. Hematopoietic
    • 4.2.2.1. Hematopoietic Market, 2018 - 2030 (USD Billion)
  • 4.2.3. Mesenchymal
    • 4.2.3.1. Mesenchymal Market, 2018 - 2030 (USD Billion)
  • 4.2.4. Neural
    • 4.2.4.1. Neural Market, 2018 - 2030 (USD Billion)
  • 4.2.5. Epithelial/Skin
    • 4.2.5.1. Epithelial/Skin Market, 2018 - 2030 (USD Billion)
  • 4.2.6. Others
    • 4.2.6.1. Others Market, 2018 - 2030 (USD Billion)
• 4.3. Human Embryonic Stem Cells (HESCs)
  • 4.3.1. Human Embryonic Stem Cells (HESCs) Market, 2018 - 2030 (USD Billion)
• 4.4. Induced Pluripotent Stem Cells (iPSCs)
  • 4.4.1. Induced Pluripotent Stem Cells (iPSCs) Market, 2018 - 2030 (USD Billion)
• 4.5. Very Small Embryonic Like Stem Cells
  • 4.5.1. Very Small Embryonic Like Stem Cells Market, 2018 - 2030 (USD Billion)

Chapter 5. Application Business Analysis

• 5.1. Stem Cells Market: Application Movement Analysis
• 5.2. Regenerative Medicine
  • 5.2.1. Regenerative Medicine Market, 2018 - 2030 (USD Billion)
  • 5.2.2. Neurology
    • 5.2.2.1. Neurology Market, 2018 - 2030 (USD Billion)
  • 5.2.3. Orthopedics
    • 5.2.3.1. Orthopedics Market, 2018 - 2030 (USD Billion)
  • 5.2.4. Oncology
    • 5.2.4.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 5.2.5. Hematology
    • 5.2.5.1. Hematology Market, 2018 - 2030 (USD Billion)
  • 5.2.6. Cardiovascular and Myocardial Infraction
    • 5.2.6.1. Cardiovascular and Myocardial Infraction Market, 2018 - 2030 (USD Billion)
  • 5.2.7. Injuries
    • 5.2.7.1. Injuries Market, 2018 - 2030 (USD Billion)
  • 5.2.8. Diabetes
    • 5.2.8.1. Diabetes Market, 2018 - 2030 (USD Billion)
  • 5.2.9. Liver Disorder
    • 5.2.9.1. Liver Disorder Market, 2018 - 2030 (USD Billion)
  • 5.2.10. Incontinence
    • 5.2.10.1. Incontinence Market, 2018 - 2030 (USD Billion)
  • 5.2.11. Others
    • 5.2.11.1. Others Market, 2018 - 2030 (USD Billion)
• 5.3. Drug Discovery and Development
  • 5.3.1. Drug Discovery and Development Market, 2018 - 2030 (USD Billion)

Chapter 6. Technology Business Analysis

• 6.1. Stem Cells Market: Technology Movement Analysis
• 6.2. Cell Acquisition
  • 6.2.1. Cell Acquisition Market, 2018 - 2030 (USD Billion)
  • 6.2.2. Bone Marrow Harvest
    • 6.2.2.1. Bone Marrow Harvest Market, 2018 - 2030 (USD Billion)
  • 6.2.3. Umbilical Blood Cord
    • 6.2.3.1. Umbilical Blood Cord Market, 2018 - 2030 (USD Billion)
  • 6.2.4. Apheresis
    • 6.2.4.1. Apheresis Market, 2018 - 2030 (USD Billion)
• 6.3. Cell Production
  • 6.3.1. Cell Production Market, 2018 - 2030 (USD Billion)
  • 6.3.2. Therapeutic Cloning
    • 6.3.2.1. Therapeutic Cloning Market, 2018 - 2030 (USD Billion)
  • 6.3.3. In-vitro Fertilization
    • 6.3.3.1. In-vitro Fertilization Market, 2018 - 2030 (USD Billion)
  • 6.3.4. Cell Culture
    • 6.3.4.1. Cell Culture Market, 2018 - 2030 (USD Billion)
  • 6.3.5. Isolation
    • 6.3.5.1. Isolation Market, 2018 - 2030 (USD Billion)
• 6.4. Cryopreservation
  • 6.4.1. Cryopreservation Market, 2018 - 2030 (USD Billion)
• 6.5. Expansion and Sub-Culture
  • 6.5.1. Expansion and Sub-Culture Market, 2018 - 2030 (USD Billion)

Chapter 7. Therapy Business Analysis

• 7.1. Stem Cells Market: Therapy Movement Analysis
• 7.2. Autologous
  • 7.2.1. Autologous Market, 2018 - 2030 (USD Billion)
• 7.3. Allogeneic
  • 7.3.1. Allogeneic Market, 2018 - 2030 (USD Billion)

Chapter 8. Application Business Analysis

• 8.1. Stem Cells Market: Application Movement Analysis
• 8.2. Infectious Diseases
  • 8.2.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
• 8.3. Immunology
  • 8.3.1. Immunology Market, 2018 - 2030 (USD Billion)
• 8.4. Oncology
  • 8.4.1. Oncology Market, 2018 - 2030 (USD Billion)
• 8.5. Stem Cells
  • 8.5.1. Stem Cells Market, 2018 - 2030 (USD Billion)
• 8.6. Neurobiology
  • 8.6.1. Neurobiology Market, 2018 - 2030 (USD Billion)
• 8.7. Others
  • 8.7.1. Other Applications Market, 2018 - 2030 (USD Billion)

Chapter 9. End Use Business Analysis

• 9.1. Stem Cells Market: End-use Movement Analysis
• 9.2. Pharmaceutical and Biotechnology Companies
  • 9.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Billion)
• 9.3. Hospitals & Cell Banks
  • 9.3.1. Hospitals & Cell Banks Market, 2018 - 2030 (USD Billion)
• 9.4. Academic & Research Institutes
  • 9.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Billion)

Chapter 10. Regional Business Analysis

• 10.1. Stem Cells Market Share By Region, 2025 & 2030
• 10.2. North America
  • 10.2.1. North America Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.2.2. U.S.
    • 10.2.2.1. Key Country Dynamics
    • 10.2.2.2. Target Disease Prevalence
    • 10.2.2.3. Competitive Scenario
    • 10.2.2.4. Regulatory Framework
    • 10.2.2.5. U.S. Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.2.3. Canada
    • 10.2.3.1. Key Country Dynamics
    • 10.2.3.2. Target Disease Prevalence
    • 10.2.3.3. Competitive Scenario
    • 10.2.3.4. Regulatory Framework
    • 10.2.3.5. Canada Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.2.4. Mexico
    • 10.2.4.1. Key Country Dynamics
    • 10.2.4.2. Target Disease Prevalence
    • 10.2.4.3. Competitive Scenario
    • 10.2.4.4. Regulatory Framework
    • 10.2.4.5. Mexico Stem Cells Market, 2018 - 2030 (USD Billion)
• 10.3. Europe
  • 10.3.1. Europe Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.2. UK
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Target Disease Prevalence
    • 10.3.2.3. Competitive Scenario
    • 10.3.2.4. Regulatory Framework
    • 10.3.2.5. UK Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.3. Germany
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Target Disease Prevalence
    • 10.3.3.3. Competitive Scenario
    • 10.3.3.4. Regulatory Framework
    • 10.3.3.5. Germany Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.4. France
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Target Disease Prevalence
    • 10.3.4.3. Competitive Scenario
    • 10.3.4.4. Regulatory Framework
    • 10.3.4.5. France Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.5. Italy
    • 10.3.5.1. Key Country Dynamics
    • 10.3.5.2. Target Disease Prevalence
    • 10.3.5.3. Competitive Scenario
    • 10.3.5.4. Regulatory Framework
    • 10.3.5.5. Italy Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.6. Spain
    • 10.3.6.1. Key Country Dynamics
    • 10.3.6.2. Target Disease Prevalence
    • 10.3.6.3. Competitive Scenario
    • 10.3.6.4. Regulatory Framework
    • 10.3.6.5. Spain Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.7. Denmark
    • 10.3.7.1. Key Country Dynamics
    • 10.3.7.2. Target Disease Prevalence
    • 10.3.7.3. Competitive Scenario
    • 10.3.7.4. Regulatory Framework
    • 10.3.7.5. Denmark Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.8. Sweden
    • 10.3.8.1. Key Country Dynamics
    • 10.3.8.2. Target Disease Prevalence
    • 10.3.8.3. Competitive Scenario
    • 10.3.8.4. Regulatory Framework
    • 10.3.8.5. Sweden Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3.9. Norway
    • 10.3.9.1. Key Country Dynamics
    • 10.3.9.2. Target Disease Prevalence
    • 10.3.9.3. Competitive Scenario
    • 10.3.9.4. Regulatory Framework
    • 10.3.9.5. Norway Stem Cells Market, 2018 - 2030 (USD Billion)
• 10.4. Asia Pacific
  • 10.4.1. Asia Pacific Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4.2. Japan
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Target Disease Prevalence
    • 10.4.2.3. Competitive Scenario
    • 10.4.2.4. Regulatory Framework
    • 10.4.2.5. Japan Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4.3. China
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Target Disease Prevalence
    • 10.4.3.3. Competitive Scenario
    • 10.4.3.4. Regulatory Framework
    • 10.4.3.5. China Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4.4. India
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Target Disease Prevalence
    • 10.4.4.3. Competitive Scenario
    • 10.4.4.4. Regulatory Framework
    • 10.4.4.5. India Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4.5. Australia
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Target Disease Prevalence
    • 10.4.5.3. Competitive Scenario
    • 10.4.5.4. Regulatory Framework
    • 10.4.5.5. Australia Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4.6. Thailand
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Target Disease Prevalence
    • 10.4.6.3. Competitive Scenario
    • 10.4.6.4. Regulatory Framework
    • 10.4.6.5. Thailand Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4.7. South Korea
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Target Disease Prevalence
    • 10.4.7.3. Competitive Scenario
    • 10.4.7.4. Regulatory Framework
    • 10.4.7.5. South Korea Stem Cells Market, 2018 - 2030 (USD Billion)
• 10.5. Latin America
  • 10.5.1. Latin America Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.5.2. Brazil
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Target Disease Prevalence
    • 10.5.2.3. Competitive Scenario
    • 10.5.2.4. Regulatory Framework
    • 10.5.2.5. Brazil Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.5.3. Argentina
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Target Disease Prevalence
    • 10.5.3.3. Competitive Scenario
    • 10.5.3.4. Regulatory Framework
    • 10.5.3.5. Argentina Stem Cells Market, 2018 - 2030 (USD Billion)
• 10.6. MEA
  • 10.6.1. MEA Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.6.2. South Africa
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Target Disease Prevalence
    • 10.6.2.3. Competitive Scenario
    • 10.6.2.4. Regulatory Framework
    • 10.6.2.5. South Africa Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.6.3. Saudi Arabia
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Target Disease Prevalence
    • 10.6.3.3. Competitive Scenario
    • 10.6.3.4. Regulatory Framework
    • 10.6.3.5. Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.6.4. UAE
    • 10.6.4.1. Key Country Dynamics
    • 10.6.4.2. Target Disease Prevalence
    • 10.6.4.3. Competitive Scenario
    • 10.6.4.4. Regulatory Framework
    • 10.6.4.5. UAE Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.6.5. Kuwait
    • 10.6.5.1. Key Country Dynamics
    • 10.6.5.2. Target Disease Prevalence
    • 10.6.5.3. Competitive Scenario
    • 10.6.5.4. Regulatory Framework
    • 10.6.5.5. Kuwait Stem Cells Market, 2018 - 2030 (USD Billion)

Chapter 11. Competitive Landscape

• 11.1. Company Categorization
• 11.2. Strategy Mapping
• 11.3. Company Market Position Analysis, 2024
• 11.4. Company Profiles/Listing
  • 11.4.1. Thermo Fisher Scientific, Inc.
    • 11.4.1.1. Overview
    • 11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.1.3. Product Benchmarking
    • 11.4.1.4. Strategic Initiatives
  • 11.4.2. STEMCELL Technologies Inc.
    • 11.4.2.1. Overview
    • 11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.2.3. Product Benchmarking
    • 11.4.2.4. Strategic Initiatives
  • 11.4.3. Merck KGaA
    • 11.4.3.1. Overview
    • 11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.3.3. Product Benchmarking
    • 11.4.3.4. Strategic Initiatives
  • 11.4.4. CellGenix GmbH
    • 11.4.4.1. Overview
    • 11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.4.3. Product Benchmarking
    • 11.4.4.4. Strategic Initiatives
  • 11.4.5. PromoCell GmbH
    • 11.4.5.1. Overview
    • 11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.5.3. Product Benchmarking
    • 11.4.5.4. Strategic Initiatives
  • 11.4.6. Takara Holdings, Inc.
    • 11.4.6.1. Overview
    • 11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.6.3. Product Benchmarking
    • 11.4.6.4. Strategic Initiatives
  • 11.4.7. Lonza
    • 11.4.7.1. Overview
    • 11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.7.3. Product Benchmarking
    • 11.4.7.4. Strategic Initiatives
  • 11.4.8. Cellular Engineering Technologies
    • 11.4.8.1. Overview
    • 11.4.8.2. Product Benchmarking
    • 11.4.8.3. Strategic Initiatives
  • 11.4.9. ATCC
    • 11.4.9.1. Overview
    • 11.4.9.2. Product Benchmarking
    • 11.4.9.3. Strategic Initiatives
  • 11.4.10. AcceGen
    • 11.4.10.1. Overview
    • 11.4.10.2. Product Benchmarking
    • 11.4.10.3. Strategic Initiatives
  • 11.4.11. Cell Applications, Inc.
    • 11.4.11.1. Overview
    • 11.4.11.2. Product Benchmarking
    • 11.4.11.3. Strategic Initiatives
  • 11.4.12. Bio-Techne
    • 11.4.12.1. Overview
    • 11.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.12.3. Product Benchmarking
    • 11.4.12.4. Strategic Initiatives